PDGFRB and neoplasm: In tumor studies, targeting both VEGF‐R2 and PDGF‐Rβ by SU6668 leads to tumor blood vessels regression by 40%, and induced EC apoptosis.70 Disruption of PDGF/PDGF‐Rβ signaling in transgenic mice resulted in failure of PC recruitment to newly formed blood vessels.